PT Medikaloka Hermina Tbk

IDX:HEAL Stock Report

Market Cap: Rp19.4t

Medikaloka Hermina Past Earnings Performance

Past criteria checks 1/6

Medikaloka Hermina's earnings have been declining at an average annual rate of -1.6%, while the Healthcare industry saw earnings declining at 1.6% annually. Revenues have been growing at an average rate of 9.2% per year. Medikaloka Hermina's return on equity is 10.1%, and it has net margins of 7%.

Key information

-1.58%

Earnings growth rate

-0.64%

EPS growth rate

Healthcare Industry Growth14.15%
Revenue growth rate9.22%
Return on equity10.07%
Net Margin7.01%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medikaloka Hermina makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

IDX:HEAL Revenue, expenses and earnings (IDR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 256,703,240469,725979,3020
31 Dec 246,717,179535,942991,4980
30 Sep 246,580,738556,666991,9040
30 Jun 246,436,894578,161970,8470
31 Mar 246,137,900519,392934,4380
31 Dec 235,784,086437,346888,7500
30 Sep 235,489,476401,911865,5100
30 Jun 235,228,871336,552857,5660
31 Mar 235,045,373296,249839,1550
31 Dec 224,901,810298,596859,8280
30 Sep 224,884,192468,353725,6830
30 Jun 225,135,152615,705819,2900
31 Mar 225,493,169823,971884,9690
31 Dec 215,869,014995,974954,1250
30 Sep 216,160,265984,4491,138,1070
30 Jun 215,782,130913,6381,033,0630
31 Mar 215,017,031684,631970,0470
31 Dec 204,416,042473,222884,6350
30 Sep 203,826,030307,234885,9730
30 Jun 203,574,963234,966842,0890
31 Mar 203,713,290270,753854,0940
31 Dec 193,630,940255,367852,7720
30 Sep 193,457,550224,197798,6230
30 Jun 193,330,819178,976806,7490
31 Mar 193,213,504143,733774,1410
31 Dec 183,058,091124,374747,3840
30 Sep 183,002,728122,143707,8020
30 Jun 182,911,81396,985636,3480
31 Mar 182,783,42699,344619,8030
31 Dec 172,678,19797,549576,7750
31 Dec 162,234,26361,996490,2370
31 Dec 151,709,02019,298381,2310

Quality Earnings: HEAL has high quality earnings.

Growing Profit Margin: HEAL's current net profit margins (7%) are lower than last year (8.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HEAL's earnings have declined by 1.6% per year over the past 5 years.

Accelerating Growth: HEAL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: HEAL had negative earnings growth (-9.6%) over the past year, making it difficult to compare to the Healthcare industry average (4.8%).

Return on Equity

High ROE: HEAL's Return on Equity (10.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 22:51
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Medikaloka Hermina Tbk is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason ChandraCGS International
Lakshmi RowterCitigroup Inc
Chelene IndrianiCLSA